[{"id":"8b19687d-558a-4223-bbd4-26df46c73f8c","acronym":"DEMAND","url":"https://clinicaltrials.gov/study/NCT04741984","created_at":"2021-02-05T12:56:19.857Z","updated_at":"2024-07-02T16:35:47.995Z","phase":"Phase 1","brief_title":"Monocyte Antigen Carrier Cells for Newly Diagnosed GBM","source_id_and_acronym":"NCT04741984 - DEMAND","lead_sponsor":"Michael Gunn","biomarkers":" MGMT • IFNG • GZMB","pipe":"","alterations":" ","tags":["MGMT • IFNG • GZMB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • MT-201 • adecatumumab (MT201)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 11/01/2025","study_completion_date":" 11/01/2025","last_update_posted":"2023-05-15"}]